Factor | Alive | Died | Р |
Dialysis before transplantation months ± S.D. | 36.45 ± 33.076 | 24.87 ± 20.458 | 0.115 |
Peritoneal dialysis | 12 (5.4%) | 3 (9.7%) | 0.406 |
CMV-seropositive donors | 22 (9.9%) | 1 (3.2%) | 0.327 |
CMV-seropositive recipients | 51 (23.0%) | 2 (6.5%) | 0.034* |
Arterial hypertension | 143 (64.4%) | 21 (67.7%) | 0.842 |
Diabetes mellitus | 18 (8.1%) | 5 (16.1%) | 0.175 |
Complications of the early postoperative period | 55 (24.8%) | 10 (32.3%) | 0.384 |
Treatment of acute rejection | 33 (14.9%) | 6 (19.4%) | 0.594 |
Prednisolone | 214 (87.3%) | 31 (100%) | 0.601 |
Mycophenolate mofetil | 166 (74.8%) | 29 (93.5%) | 0.021* |
Azathioprine | 51 (23.0%) | 1 (3.2%) | 0.008* |
Cyclosporine А | 141 (63.5%) | 21 (67.7%) | 0.695 |
Tacrolimus | 65 (29.3%) | 8 (25.8%) | 0.833 |
Everolimus | 4 (1.8%) | 0 (0%) | 1.000 |
Sirolimus | 10 (4.5%) | 1 (3.2%) | 1.000 |